The European Medicines Agency’s request to make all clinical trial data available is key to countering bias in publication, drug prescription practice and health policy. Continue reading →
→ 3 Comments
Posted in Biotechnology, Development, Medicine, Methodology, Risk assessment
Tagged clinical research, medical research
Enter your email address to follow this blog and receive notifications of new posts by email.
Get every new post delivered to your Inbox.
Join 2,161 other followers